Clinical Trials Directory

Trials / Completed

CompletedNCT03840538

Probiotics as a Prophylaxis to Prevent Clinical Manifestations of Oral Candidosis in Patients With Sjogren's Syndrome

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
30 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Sjogren's syndrome is an autoimmune chronic disease. It has two forms Primary Sjogren's syndrome charactrized by dry eyes and dry mouth. Secondary Sjogren's syndrome characterized by rheumatoid diseases as rheumatoid arthritis, scleroderma and lupus erythematosus. SS patients are most liable to oral candidiasis , so they need prophylaxis aganist oral candidiasis. Probiotic bacteria are live microorganisms that when administered in adequate amounts confer benefits to health.Probiotics are commonly used as a prophylaxis aganist oral candidosis.

Conditions

Interventions

TypeNameDescription
DRUGProbiotic Product - Capprobiotic capsule complex composed of L.acidophilus, L. bulgaricus, Streptococcus thermophilus, and Bifidobacterium bifidus

Timeline

Start date
2018-01-01
Primary completion
2018-12-01
Completion
2019-01-01
First posted
2019-02-15
Last updated
2019-02-15

Locations

1 site across 1 country: Egypt

Regulatory

Source: ClinicalTrials.gov record NCT03840538. Inclusion in this directory is not an endorsement.

Probiotics as a Prophylaxis to Prevent Clinical Manifestations of Oral Candidosis in Patients With Sjogren's Syndrome (NCT03840538) · Clinical Trials Directory